Swati Jayaram | Medicine | Best Researcher Award

Published on by Global Diseases Research

Best Researcher Award

Swati Jayaram
The Ohio State University

Swati Jayaram
Affiliation The Ohio State University
Country India
Scopus ID 57966951000
Documents 4
Citations 1
h-index 1
Subject Area Medicine
Event Global Diseases Research Awards

The Best Researcher Award recognizes scholarly achievement, research productivity, and meaningful contributions to scientific advancement. Swati Jayaram of The Ohio State University has developed an academic profile within the field of medicine through peer-reviewed publications and participation in scientific research activities. Her documented scholarly record demonstrates engagement with evidence-based investigation and knowledge dissemination within the biomedical sciences.[1]

Abstract

Swati Jayaram is affiliated with The Ohio State University and has contributed to the field of medicine through scholarly publications and academic research activities. Her documented research profile reflects participation in scientific investigations that support evidence-based understanding and clinical knowledge development. Available bibliometric indicators demonstrate a developing publication record with measurable citation activity. The Best Researcher Award recognizes individuals whose academic efforts contribute to scientific communication, research quality, and professional advancement. Based on available scholarly metrics and publication records, her work represents ongoing engagement in medical research and supports broader objectives associated with innovation, scientific inquiry, and academic excellence within healthcare-related disciplines.[1]

Keywords

Medicine, Medical Research, Academic Excellence, Scientific Publications, Healthcare Research, Evidence-Based Medicine, Scholarly Impact, Research Productivity, Best Researcher Award, Global Diseases Research Awards.

Introduction

Academic recognition programs play an important role in highlighting research achievements and encouraging continued scientific advancement. The Best Researcher Award acknowledges individuals who demonstrate commitment to scholarly investigation, publication quality, and professional contributions that strengthen knowledge development across scientific disciplines and healthcare-related research environments.[2]

Research Profile

Swati Jayaram is associated with The Ohio State University and maintains a documented research presence within the medical sciences. Bibliometric information available through Scopus indicates four indexed publications, one citation, and an h-index of one, reflecting an emerging scholarly profile supported by peer-reviewed academic contributions.[1]

Research Contributions

Research contributions associated with Swati Jayaram demonstrate participation in scientific inquiry relevant to medicine and healthcare. Through publication activities and collaboration within academic environments, her work contributes to the dissemination of knowledge, supports evidence-based understanding, and strengthens the broader framework of medical research and scholarly communication.[1]

Publications

The publication record indexed under the Scopus author profile demonstrates engagement with peer-reviewed scholarly dissemination. Publications contribute to academic visibility, facilitate scientific discussion, and provide measurable outputs that support the evaluation of research performance. Such outputs remain important indicators of sustained participation in scholarly activities.[1]

Research Impact

Research impact is commonly assessed through publication metrics, citation performance, and scholarly visibility. Available indicators associated with Swati Jayaram suggest developing influence within the academic literature. Citation activity, although limited in quantity, demonstrates that published work has entered the scientific record and contributed to ongoing scholarly engagement.[1]

Award Suitability

The Best Researcher Award evaluates research productivity, academic commitment, publication quality, and professional contributions. Based on documented scholarly activities, Swati Jayaram demonstrates characteristics aligned with the objectives of academic recognition programs. Her participation in medical research and scientific publication supports consideration within award frameworks focused on research excellence and scholarly achievement.[2]

Conclusion

Swati Jayaram’s academic profile reflects involvement in medical research, peer-reviewed publication, and scholarly communication. Her documented contributions, supported by indexed research outputs and citation activity, demonstrate engagement with scientific advancement. These characteristics align with the principles recognized by the Best Researcher Award and highlight ongoing participation in academic research initiatives.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Swati Jayaram, Author ID 57966951000. Scopus.https://www.scopus.com/authid/detail.uri?authorId=57966951000
  2. Global Diseases Research Awards. (n.d.). Best Researcher Award and recognition framework.https://globaldiseases.org/
  3. Gillespie, M. L., Jayaram, S., Eisner, M., Sliemers, S., Pasley, K., McCoy, K., & Krivchenia, K. (2025). Edinburgh postnatal depression scale score elevation in caregivers of infants with cystic fibrosis. Pediatric Pulmonology, 60(1), e27364. https://doi.org/10.1002/ppul.27364
  4. Jayaram, S., Khuhro, A., Krivchenia, K., & Kalra, M. (2026). Frontal lobe epilepsy presenting as parasomnia in a child on BiPAP for severe obstructive sleep apnea. Sleep, 49(Supplement_1), A597. https://doi.org/10.1093/sleep/zsag091.1339

“`

Andrew Plodkowski | Diagnostic Tools | Best Researcher Award

Published on by Global Diseases Research

Best Researcher Award

Andrew Plodkowski
Affiliation Memorial Sloan Kettering Cancer Center
Country United States
Scopus ID 57211748497
Documents 84
Citations 9,922
h-index 39
Subject Area Diagnostic Tools
Event Global Diseases Research Awards

Andrew Plodkowski of Memorial Sloan Kettering Cancer Center, United States, is recognized for his contributions to clinical research and diagnostic innovation within oncology. The Best Researcher Award highlights his scholarly excellence and impactful role in advancing scientific knowledge through translational medicine. His academic and clinical work focuses on the development and refinement of diagnostic tools that enhance accuracy in disease detection and support more precise, evidence-based clinical decision-making. Through sustained engagement in multidisciplinary research, he has contributed to improving patient outcomes and strengthening the integration of research findings into practical oncology care, reflecting a strong commitment to scientific progress and medical advancement.

Abstract

This article presents a scholarly overview of Andrew Plodkowski’s academic and research contributions in the field of diagnostic tools. His research activity reflects a consistent focus on improving clinical methodologies and enhancing disease detection frameworks. The Best Researcher Award highlights his academic influence, interdisciplinary collaboration, and measurable scientific output within a leading cancer research institution [2].

Keywords

Diagnostic Tools, Cancer Research, Clinical Innovation and Translational Medicine

Introduction

The field of diagnostic medicine continues to evolve through advancements in imaging, biomarker identification, and computational analysis. Within this context, Andrew Plodkowski’s contributions at Memorial Sloan Kettering Cancer Center represent a sustained effort toward improving diagnostic precision. His research aligns with global priorities in early disease detection and clinical efficiency.

Research Profile

Andrew Plodkowski’s research profile reflects extensive engagement in clinical oncology and diagnostic innovation. With a Scopus-indexed output of 84 documents and over 9,922 citations, his scholarly presence demonstrates significant academic reach and interdisciplinary collaboration. His h-index of 39 further indicates consistent research influence within the scientific community [1].

Research Contributions

His research contributions include advancements in imaging-based diagnostics, clinical evaluation frameworks, and data-driven oncology methodologies. These efforts support improved patient stratification and treatment planning in complex disease environments.

Publications

The publication record of Andrew Plodkowski spans peer-reviewed journals focused on oncology, radiology, and diagnostic science. His work contributes to the broader scientific discourse on precision medicine and clinical decision support systems.

Research Impact

The impact of his research is evident in citation metrics and its application in clinical settings. His contributions support improved diagnostic accuracy and have influenced methodological approaches in medical imaging and oncology research.

Award Suitability

The Best Researcher Award recognizes individuals with sustained scholarly excellence and measurable scientific impact. Andrew Plodkowski’s research output, citation profile, and institutional affiliation position him as a strong candidate for recognition under the Global Diseases Research Awards framework [3].

Conclusion

In conclusion, Andrew Plodkowski’s academic contributions reflect a sustained commitment to advancing diagnostic science. His work continues to support innovation in clinical research and reinforces the importance of evidence-based approaches in modern healthcare systems.

References

  1. Elsevier. (n.d.). Scopus author details: Andrew Plodkowski, Author ID 57211748497. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57211748497
  2. Global Diseases Research Awards. (n.d.). Official Award Framework and Research Recognition Guidelines.
    https://globaldiseases.org/
  3. Arbour, K. C., Mezquita, L., Long, N., Rizvi, H., Auclin, E., Ni, A., Martínez-Bernal, G., Ferrara, R., Lai, W. V., Hendriks, L. E. L., Sabari, J. K., Caramella, C., Plodkowski, A. J., Halpenny, D., Chaft, J. E., Planchard, D., Riely, G. J. (2018). Impact of baseline steroids on efficacy of programmed cell death-1 and programmed death-ligand 1 blockade in patients with non–small-cell lung cancer.
    https://doi.org/10.1200/JCO.2018.79.0006 

  4. Derosa, L., Hellmann, M. D., Spaziano, M., Halpenny, D., Fidelle, M., Rizvi, H., Long, N., Plodkowski, A. J., Arbour, K. C., Chaft, J. E., Rouche, J. A., Zitvogel, L., Zalcman, G., Albiges, L., Escudier, B., Routy, B. (2018). Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancer.
     https://doi.org/10.1200/JCO.2018.79.0005

  5. Drilon, A., Rekhtman, N., Arcila, M. E., Wang, L., Ni, A., Albano, M., Van Voorthuysen, M., Somwar, R., Smith, R. S., Montecalvo, J., Plodkowski, A. J., Ginsberg, M. S., Riely, G. J., Rudin, C. M., Ladanyi, M., Kris, M. G. (2016). Cabozantinib in patients with advanced RET-rearranged non-small-cell lung cancer: An open-label, single-centre, phase 2, single-arm trial.
    https://doi.org/10.1056/NEJMoa1502309

Branko Dujovic | Dermatoncology | Innovative Research Award

Published on by Global Diseases Research

Innovative Research Award

Researcher Information
Affiliation Military Medical Academy
Country Serbia
Scopus ID 58245030500
Documents 6
Citations 21
h-index 2
Subject Area Dermatoncology
Event Global Diseases Research Awards
ORCID 0009-0009-1497-5777

Branko Dujovic of the Military Medical Academy, Serbia, is recognized for his contributions to medical research, with a particular focus on dermatoncology. The Innovative Research Award highlights his scholarly excellence, scientific integrity, and meaningful impact on advancing clinical science. Through his published research, interdisciplinary collaboration, and commitment to evidence-based medical investigation, he has built a strong academic profile. His work emphasizes improvements in disease diagnosis, evaluation of treatment strategies, and enhancement of patient-centered healthcare outcomes, reflecting a consistent dedication to advancing knowledge and strengthening modern clinical practice in oncology and dermatology-related research.

Abstract

Branko Dujovic is a researcher affiliated with the Military Medical Academy in Serbia whose scholarly activities contribute to the field of dermatoncology. Through peer-reviewed publications, clinical investigations, and collaborative research efforts, he has supported the advancement of scientific understanding related to skin cancer and associated diseases. His academic record, including indexed publications, citations, and international researcher identifiers, demonstrates engagement with contemporary medical science. The Innovative Research Award acknowledges researchers whose work promotes scientific progress, encourages evidence-based practice, and contributes to improving healthcare knowledge through responsible and impactful research activities.[1]

Keywords

Dermatoncology, Clinical Research, Medical Science, Skin Cancer Research, Academic Excellence, Innovative Research Award, Healthcare Innovation, Disease Investigation, Scientific Publications, Global Diseases Research Awards.

Introduction

Dermatoncology represents a specialized area of medicine focused on understanding, diagnosing, and managing skin-related cancers. Researchers working within this discipline contribute valuable evidence supporting clinical decision-making and patient care improvements. Branko Dujovic has participated in research activities that align with these objectives and support ongoing scientific advancement within the medical community.[1]

Research Profile

Affiliated with the Military Medical Academy, Branko Dujovic maintains an academic profile indexed within international scholarly databases. His publication record includes research outputs relevant to dermatoncology and related medical disciplines. The available metrics indicate active participation in scientific communication and engagement with peer-reviewed research environments.[4]

Research Contributions

The research contributions of Branko Dujovic are associated with clinical and scientific investigations addressing disease mechanisms, patient outcomes, and healthcare practices. His studies support the broader body of medical knowledge by providing data-driven insights that may assist clinicians, researchers, and healthcare institutions in understanding dermatological oncology challenges.[2]

Publications

The researcher has produced six indexed documents that collectively contribute to scholarly discussion within his field. These publications demonstrate participation in scientific dissemination and provide evidence of sustained academic activity. Published work remains an important indicator of research productivity, professional collaboration, and contribution to medical literature.

Research Impact

Citation metrics indicate that the researcher’s publications have been referenced by other scholars, reflecting engagement within the scientific community. While quantitative indicators provide only one measure of influence, citations and indexing demonstrate the visibility of research outputs and their relevance to ongoing academic discussions.[1]

Award Suitability

Branko Dujovic demonstrates characteristics associated with the objectives of the Innovative Research Award, including scholarly productivity, scientific engagement, and commitment to advancing medical knowledge. His documented research activities, institutional affiliation, and contributions to dermatoncology support consideration for recognition within the Global Diseases Research Awards program.[3]

Conclusion

The academic profile of Branko Dujovic reflects participation in meaningful scientific research within dermatoncology. Through publications, citation impact, and professional engagement, he contributes to the advancement of healthcare knowledge. Recognition through the Innovative Research Award highlights the value of continued research efforts that support evidence-based medicine and scientific progress.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Branko Dujovic, Author ID 58245030500. Scopus
    .https://www.scopus.com/authid/detail.uri?authorId=58245030500
  2. ORCID. (n.d.). Researcher profile and scholarly identifier for Branko Dujovic
    .    https://orcid.org/0009-0009-1497-5777
  3. Global Diseases Research Awards. (n.d.). Innovative Research Award and recognition framework.
    https://globaldiseases.org/
  4. Dujovic, B., Popovic, A., Jalovcic Suljevic, A., Cikota-Aleksic, B., Balic, M., Salatic, I., Pavlica, J., Schnecko, P., Mesti, T., Terzo, M., Bicakcic Filipovic, E., & Kandolf, L. (2026). Prognostic significance of inflammatory biomarkers in first-line immunotherapy for metastatic melanoma: Multicentric study (Version 1). Preprints.org.
    https://doi.org/10.20944/preprints202604.1631.v1
  5. Torres-Zurita, A., Vázquez-Montero, L., Gallego-López, L., Mediano-Rambla, M. D., & de la Cruz-Merino, L. (2023). Sarcoidosis-like reaction induced by immune checkpoint inhibitor in a patient with hepatocellular carcinoma: A case report. Frontiers in Immunology, 14, 1150128.
    https://doi.org/10.3389/fimmu.2023.1150128

Anis Chaudhary | Stress Physiology | Research Excellence Award

Published on by Global Diseases Research

Research Excellence Award

Research Profile
Affiliation Imam Mohammad Ibn Saud Islamic University
Country Saudi Arabia
Scopus ID 55419607600
Documents 204
Citations 9,439
h-index 37
Subject Area Stress Physiology
Event Global Diseases Research Awards
ORCID 0000-0002-1506-7836

Anis Chaudhary is an academic researcher affiliated with Imam Mohammad Ibn Saud Islamic University, Saudi Arabia, whose scholarly work in stress physiology and related biomedical sciences reflects growing research visibility through publications, citation impact, and interdisciplinary collaborations within international scientific communities. His contributions span biomedical research areas focused on physiological stress responses, with an emphasis on advancing experimental and clinical understanding through collaborative academic engagement..[1]

Abstract

This article presents an overview of the academic contributions and research profile of Anis Chaudhary in the field of stress physiology and biomedical sciences. The researcher has contributed extensively through scholarly publications, collaborative investigations, and citation-based academic influence within international research communities. Bibliometric indicators including publication volume, citation performance, and h-index demonstrate measurable scientific visibility and sustained engagement with emerging physiological and disease-related research themes. The profile further reflects participation in interdisciplinary scientific activities associated with health sciences, molecular biology, and stress-related biomedical investigations recognized within global academic indexing systems and scholarly evaluation frameworks.

Keywords

Stress Physiology, Biomedical Research, Molecular Biology, Scientific Publications, Citation Analysis, Research Impact, Academic Recognition, Disease Research, Physiological Stress, Interdisciplinary Science.

Introduction

Stress physiology represents a significant scientific field examining physiological responses associated with environmental, molecular, and pathological stress mechanisms. Researchers contributing to this discipline support advancements in disease understanding, cellular adaptation studies, and biomedical innovation through experimental and interdisciplinary scientific investigations.

Research Profile

The academic profile of Anis Chaudhary demonstrates sustained scholarly productivity reflected through 204 indexed documents, 9,439 citations, and an h-index of 37 according to Scopus-based metrics. These indicators illustrate substantial research dissemination and continued citation engagement across biomedical and physiological research domains.

Research Contributions

Research contributions associated with Anis Chaudhary include studies connected to physiological stress responses, molecular signaling pathways, disease-related mechanisms, and biomedical analytical approaches. Scholarly activities within these areas contribute to broader scientific understanding regarding health conditions and physiological adaptation processes.[3]

Publications

The publication record includes articles indexed within international scientific databases and journals related to biomedical sciences and physiological research. DOI-indexed publications further support accessibility, citation tracking, and scholarly verification within global academic communication systems.[4]

Research Impact

Citation metrics and publication visibility indicate measurable academic influence within the scientific community. The researcher’s citation performance demonstrates continued scholarly engagement and recognition across interdisciplinary biomedical fields involving physiology, disease mechanisms, and experimental scientific investigations.[1]

Award Suitability

The documented research productivity, citation-based visibility, and interdisciplinary scientific contributions support suitability for recognition within the Global Diseases Research Awards framework. Academic indicators and publication continuity reflect active participation in internationally accessible biomedical research environments.[2]

Conclusion

Anis Chaudhary’s scholarly profile reflects sustained contributions to stress physiology and biomedical sciences through publications, citation influence, and international research visibility. The academic record demonstrates measurable scientific engagement supporting recognition within professional and interdisciplinary research evaluation frameworks.

References

  1. Elsevier. (n.d.). Scopus author details: Anis Chaudhary, Author ID 55419607600. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=55419607600
  2. Global Diseases Research Awards. (n.d.). Academic recognition and award evaluation criteria.
    https://globaldiseases.org/
  3. Prakash, J., Chaudhary, A. A., Somvanshi, A., Lal, B., Suman, Rudayni, H. A., Raza, N., Fazil, M., Ahmad, T., Ravi, K., Jasrotia, R., & Jara, A. D. (2026). Highly active Zn-doped cobalt ferrite catalysts for photocatalytic and electrocatalytic hydrogen production. Environmental Sciences Europe, 38, Article 56.
    https://doi.org/10.1186/s12302-025-01289-1
  4. Hamad, A. A., Ali, M. A. M., Chaudhary, A. A., Obaydo, R. H., Saleh, S. F., Ibrahim, A. M. M., Mawkili, W., & Maslamani, N. (2026). Coupling MgSO₄-assisted SALLE with a fluorimetric turn-off strategy for the determination of cinacalcet HCl in pharmaceutical and human matrices. Scientific Reports, 16, Article 13756.
    https://doi.org/10.1038/s41598-026-41887-4

  5. Elmorsy, E. A., Amer, M. M., Hamad, R. S., Abdel-Hamed, M. R., Farrag, A. A., Alorini, M., Khodeir, M. M., Ali, M. A. M., Alhowail, A. H., Mohamed, E. A., Alsalloom, A. A., Alsaykhan, H., Alsoqih, N. S., Ata, H. S., Sameh, A., Chaudhary, A. A., & Saber, S. (2026). Breaking a mitochondrial danger–STING feed-forward amplifier preserves alveolar-capillary architecture and dampens interferon-chemokine signaling in acute lung injury. Tissue and Cell.
    https://doi.org/10.1016/j.tice.2026.103514

Evangelos Cholongitas | Hepatology | Best Researcher Award

Published on by Global Diseases Research

Best Researcher Award

Evangelos Cholongitas, Laiko General Hospital of Athens, Greece

Evangelos Cholongitas
Affiliation Laiko General Hospital of Athens
Country Greece
Scopus ID 55399959500
Documents 323
Citations 12,006
h-index 57
Subject Area Hepatology
Event Global Diseases Research Awards
ORCID 0000-0002-3645-582X
Google Scholar View Profile

The Best Researcher Award recognizes the scholarly achievements and scientific contributions of Evangelos Cholongitas, a clinician and academic researcher affiliated with the Laiko General Hospital of Athens in Greece. His work in hepatology has contributed to the advancement of liver disease management, transplantation medicine, portal hypertension research, and evidence-based clinical hepatology.[1] Through a substantial body of peer-reviewed publications, citation impact, and international collaboration, Cholongitas has established a recognized academic profile within gastroenterology and liver research communities.[2]

Abstract

Evangelos Cholongitas is recognized for sustained contributions to hepatology and liver transplantation research. His scientific work has addressed major clinical challenges related to chronic liver disease, portal hypertension, transplantation outcomes, renal impairment in liver disorders, and evidence-based therapeutic approaches. The Best Researcher Award acknowledges his academic productivity, citation influence, and continuing role in advancing translational and clinical hepatology research within international scientific communities.[1]

Keywords

Hepatology, Liver Transplantation, Gastroenterology, Chronic Liver Disease, Clinical Research, Portal Hypertension, Hepatic Disorders, Evidence-Based Medicine, Liver Failure, Academic Research Excellence

Introduction

Hepatology remains an important medical discipline focused on the diagnosis, management, and prevention of liver-related diseases. Research in this area contributes significantly to improving patient outcomes in cirrhosis, viral hepatitis, liver transplantation, metabolic liver disease, and hepatocellular carcinoma.[4] Evangelos Cholongitas has contributed extensively to these areas through clinical studies, systematic reviews, and collaborative investigations that support evidence-based hepatology practice.[2]

Research Profile

Evangelos Cholongitas has developed a comprehensive academic profile in hepatology with research interests spanning liver transplantation, chronic liver disease, portal hypertension, and transplantation-associated complications. His publication portfolio includes peer-reviewed journal articles, collaborative studies, and evidence synthesis reports indexed in international academic databases.[1]

Research Contributions

The research contributions of Evangelos Cholongitas are associated with clinically relevant investigations into liver disease progression, transplantation outcomes, and complications associated with hepatic dysfunction. His studies frequently evaluate diagnostic indicators, patient survival factors, renal impairment in liver disease, and post-transplant clinical management.

Publications

Evangelos Cholongitas has contributed to numerous publications in hepatology and transplantation medicine. Representative publication themes include chronic liver disease management, transplantation outcomes, renal dysfunction in cirrhosis, and portal hypertension research.[4]

Research Impact

The scholarly impact of Evangelos Cholongitas is reflected in his extensive citation metrics, publication output, and h-index performance within hepatology-related scientific literature. Citation indicators demonstrate sustained engagement with his research findings across international academic and clinical communities.[1]

Award Suitability

The Best Researcher Award recognizes measurable academic influence, scholarly productivity, and sustained scientific engagement. Evangelos Cholongitas demonstrates these criteria through a combination of publication activity, international citation impact, and contributions to clinically relevant hepatology research.

Conclusion

Evangelos Cholongitas has contributed substantially to hepatology and transplantation medicine through sustained clinical research, publication activity, and evidence-based scientific investigations. His scholarly work addresses important aspects of chronic liver disease management and transplantation outcomes, supporting advancements in patient care and academic hepatology.[2] Recognition through the Best Researcher Award reflects his continuing role in international liver disease research and academic medicine.

References

1. Elsevier. (n.d.). Scopus author details: Evangelos Cholongitas (Author ID: 55399959500). Scopus. https://www.scopus.com/authid/detail.uri?authorId=55399959500

2. Google Scholar. (n.d.). Evangelos Cholongitas citation profile.
https://scholar.google.com/citations?user=Mur4BnEAAAAJ&hl=en

3. Marelli, L., Stigliano, R., Triantos, C., Senzolo, M., Cholongitas, E., Davies, N., Tibballs, J., Meyer, T., Patch, D. W., & Burroughs, A. K. (2007). Transarterial therapy for hepatocellular carcinoma: Which technique is more effective? A systematic review of cohort and randomized studies. CardioVascular and Interventional Radiology, 30(1), 6–25. https://doi.org/10.1007/s00270-006-0062-3

4. Tsochatzis, E. A., Gurusamy, K. S., Ntaoula, S., Cholongitas, E., Davidson, B. R., & Burroughs, A. K. (2011). Elastography for the diagnosis of severity of fibrosis in chronic liver disease: A meta-analysis of diagnostic accuracy. Journal of Hepatology.
https://doi.org/10.1016/j.jhep.2010.07.033

5. Cholongitas, E., Papatheodoridis, G. V., Vangeli, M., Terreni, N., Patch, D., & Burroughs, A. K. (2006). Systematic review: The model for end-stage liver disease—Should it replace Child-Pugh’s classification for assessing prognosis in cirrhosis? Alimentary Pharmacology & Therapeutics, 24(6), 859–870.
https://doi.org/10.1111/j.1365-2036.2005.02691.x

Cleophas Kyama | Human Papilloma Virus | Research Excellence Award

Published on by Global Diseases Research

Research Excellence Award

Cleophas Kyama
Jomo Kenyatta University Of Agriculture And Technology
Research Profile
Affiliation Jomo Kenyatta University Of Agriculture And Technology
Country Kenya
Scopus ID 57216717397
Documents 65
Citations 2,698
h-index 29
Subject Area Human Papilloma Virus
Event Global Diseases Research Awards
ORCID 0000-0001-6459-1514

The Research Excellence Award recognizes distinguished scholarly achievement and sustained scientific contribution in the field of Human Papilloma Virus research. Cleophas Kyama, affiliated with Jomo Kenyatta University Of Agriculture And Technology in Kenya, has contributed to interdisciplinary biomedical investigations involving infectious diseases, epidemiology, diagnostics, and public health research. The researcher’s scholarly profile demonstrates a substantial publication record, notable citation performance, and measurable academic influence within international scientific literature.[1]

Abstract

This article presents an academic overview of Cleophas Kyama and the researcher’s eligibility for recognition through the Research Excellence Award under the Global Diseases Research Awards initiative. The profile highlights scholarly productivity, citation performance, research engagement in Human Papilloma Virus investigations, and contribution to public health-oriented scientific discourse. With a Scopus-indexed publication record and measurable citation influence, the researcher demonstrates sustained participation in disease-related biomedical research and collaborative scientific development.[1][2]

Keywords

Human Papilloma Virus, Biomedical Research, Public Health, Infectious Diseases, Scientific Publications, Epidemiology, Research Excellence Award, Citation Impact, Academic Recognition, Disease Research

Introduction

Contemporary biomedical research increasingly emphasizes interdisciplinary collaboration, evidence-based disease management, and translational scientific advancement. Researchers engaged in Human Papilloma Virus studies contribute to global understanding of viral pathogenesis, diagnostics, epidemiological surveillance, and preventive healthcare systems. Academic recognition programs such as the Global Diseases Research Awards acknowledge researchers who demonstrate long-term commitment to impactful scientific inquiry and publication excellence.[3]

Research Profile

The scholarly record of Cleophas Kyama indicates active engagement in scientific publication and research dissemination within biomedical and disease-oriented disciplines. The researcher’s Scopus profile documents 65 indexed publications alongside 2,698 citations and an h-index of 29, suggesting consistent citation visibility and ongoing relevance within the academic community.[1]

Research Contributions

Research activities associated with Cleophas Kyama have contributed to scientific understanding within the broader field of infectious disease and Human Papilloma Virus research. Such investigations commonly support improved diagnostic approaches, epidemiological assessments, and healthcare interventions designed to reduce disease burden in affected populations.[4]

Publications

The publication portfolio associated with Cleophas Kyama includes research articles indexed within internationally recognized scientific databases. The researcher’s scholarly work contributes to ongoing biomedical discourse related to infectious diseases, public health, and disease management.[1]

Research Impact

The researcher’s impact is also reflected through institutional affiliation, publication continuity, and participation in internationally accessible scientific databases. Such indicators support recognition within academic evaluation frameworks focused on scientific productivity, citation performance, and interdisciplinary contribution.[2]

Award Suitability

The Research Excellence Award under the Global Diseases Research Awards framework recognizes researchers who exhibit sustained scientific engagement, publication quality, and measurable scholarly influence. Based on the documented research profile, Cleophas Kyama demonstrates several characteristics aligned with the objectives of the award program.[3]

Conclusion

Cleophas Kyama represents an academically active researcher with demonstrated contributions to Human Papilloma Virus and disease-oriented biomedical investigations. The researcher’s publication metrics, citation indicators, and institutional affiliation collectively support recognition through the Research Excellence Award. Continued scholarly engagement and participation in internationally indexed research dissemination are likely to further strengthen the researcher’s scientific impact and contribution to global health research initiatives.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Cleophas Kyama, Author ID 57216717397. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57216717397
  2. ORCID. (n.d.). ORCID profile of Cleophas Kyama.
    https://orcid.org/0000-0001-6459-1514
  3. Global Diseases Research Awards. (n.d.). Research Excellence Award guidelines and recognition framework.
    https://globaldiseases.org/
  4. Elbasyouni, A., Kyama, M. C., El-Shemy, H. A., & Mwitari, P. G. (2025). Computational investigation and experimental validation of the molecular mechanism of Solanecio mannii aqueous roots extract against cervical cancer. PLOS ONE, 20(5), e0323680. https://doi.org/10.1371/journal.pone.0323680
  5. Elbasyouni, A., Kyama, M. C., El-Shemy, H. A., & Mwitari, P. G. (2025). Computational investigation and experimental validation of the molecular mechanism of Solanecio mannii aqueous roots extract against cervical cancer. PLOS ONE, 20(5), e0323680. https://doi.org/10.1371/journal.pone.0323680

Samir Abbès | Mycotoxicology | Research Excellence Award

Published on by Global Diseases Research

Research Excellence Award

Samir Abbès — Higher Institute of Biotechnology of Monastir

Research Profile
Affiliation Higher Institute of Biotechnology of Monastir
Country Tunisia
Scopus ID 13407983200
Documents 46
Citations 1471
h-index 24
Subject Area Mycotoxicology
Event Global Diseases Research Awards

The Research Excellence Award recognizes scholarly achievements and sustained scientific contributions within the interdisciplinary field of mycotoxicology and disease-related biosciences. Samir Abbès, affiliated with the Higher Institute of Biotechnology of Monastir, Tunisia, has contributed to scientific investigations concerning fungal toxins, food safety, toxicological assessment, and public health implications associated with mycotoxin exposure.[1] His academic profile demonstrates measurable research impact through peer-reviewed publications, citation performance, and collaborative scientific activity within international research networks.[2]

Abstract

This academic recognition profile documents the scholarly activities and scientific contributions of Samir Abbès in the field of mycotoxicology. The profile highlights research productivity, publication metrics, interdisciplinary collaboration, and scientific impact associated with toxicological investigations and food safety sciences. Particular emphasis is placed on the evaluation of fungal toxins, biological risk assessment, and disease-related environmental health research. Citation performance and bibliometric indicators further demonstrate sustained academic engagement and international research visibility.[1

Keywords

  • Mycotoxicology
  • Food Safety
  • Toxicology
  • Disease Research
  • Fungal Contamination
  • Biotechnology
  • Research Excellence Award
  • Global Diseases Research Awards

Introduction

Mycotoxicology represents a critical area of biomedical and environmental research due to the widespread occurrence of fungal toxins in agricultural products and food systems. Research in this discipline contributes to understanding toxin biosynthesis, contamination pathways, toxicological mechanisms, and public health risks. Samir Abbès has participated in scientific studies associated with toxin monitoring, toxicological analysis, and preventive biotechnology approaches related to foodborne diseases and contamination risks.[2]

Research Profile

Samir Abbès is affiliated with the Higher Institute of Biotechnology of Monastir in Tunisia and has developed a scholarly profile focused on toxicological sciences, fungal contamination analysis, and food safety research. Bibliometric records indexed through Scopus identify 46 scholarly documents associated with the author profile and an h-index of 24, indicating sustained citation influence within the scientific community.[1]

Research Contributions

The research contributions associated with Samir Abbès primarily address toxicological assessments of mycotoxins and their implications for food quality and human health. Scientific investigations in this field commonly involve analytical detection methods, exposure evaluation, toxicological pathways, and mitigation strategies intended to reduce contamination risks.[5]

Publications

Selected research publications and indexed scholarly outputs demonstrate engagement with toxicological and bioscience research topics. Representative publication themes include fungal toxin characterization, toxic effects analysis, and biotechnology applications in food safety monitoring.[2]

Research Impact

Bibliometric indicators demonstrate measurable academic impact associated with the research profile. Citation metrics and h-index performance indicate that published studies have contributed to scientific dialogue and have been referenced within international research literature. Such indicators are commonly used to evaluate research visibility, influence, and scholarly dissemination.[1]

Award Suitability

The scholarly profile of Samir Abbès aligns with the objectives of the Global Diseases Research Awards due to demonstrated contributions in toxicology, disease-related bioscience, and environmental health research. Publication productivity, citation performance, interdisciplinary engagement, and sustained scientific activity collectively support consideration for research excellence recognition.

Conclusion

Samir Abbès has established a research profile characterized by scientific contributions in mycotoxicology, toxicological assessment, and food safety sciences. Bibliometric indicators, publication activity, and interdisciplinary engagement demonstrate sustained participation in internationally relevant scientific research. The Research Excellence Award profile reflects scholarly achievements associated with disease-related bioscience investigations and environmental health studies.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Samir Abbès, Author ID 13407983200. Scopus
    .https://www.scopus.com/authid/detail.uri?authorId=13407983200
  2. Global Diseases Research Awards. (n.d.). Research Excellence Award program overview
    .    https://globaldiseases.org/
  3. Zinedine, A., Durand, N., Meile, J.-C., Abbès, S., Ben Salah-Abbès, J., & Brabet, C. (2025). Determination of 22 mycotoxins in wheat grains cultivated in two Moroccan climatic areas by UHPLC-MS/MS. Food Chemistry, 495, 146356.
    https://doi.org/10.1016/j.foodchem.2025.146356
  4. Dhif, H., Ben Salah-Abbès, J., Abbès, S., Calleja-Gómez, M., Pallarés, N., & Berrada, H. (2025). Comparative study of phenolic profile and antioxidant activities of different parts of Ziziphus lotus using aqueous, hydroalcoholic and pulsed electric field extractions. Microchemical Journal, Article 114815.
    https://doi.org/10.1016/j.microc.2025.114815
  5. World Health Organization. (n.d.). Mycotoxins and public health implications
    .    https://www.who.int/news-room/fact-sheets/detail/mycotoxins

Gulnara Yuldasheva | Drug Synergy | Women Researcher Award

Published on by Global Diseases Research

Women Researcher Award

Research Profile
Affiliation Scientific Center for Anti-Infective Drug
Country Kazakhstan
Scopus ID 21735405800
Documents 7
Citations 35
h-index 5
Subject Area Drug synergy
Event Global Diseases Research Awards
ORCID 0000-0003-2881-0307

Gulnara Yuldasheva is associated with the Scientific Center for Anti-Infective Drug in Kazakhstan and has contributed to the advancement of research in drug synergy and anti-infective therapeutic studies. Her scholarly work reflects a focused engagement in antimicrobial research, pharmaceutical sciences, and collaborative approaches to disease-related investigations. The academic profile demonstrates measurable research visibility through indexed publications, citations, and international scholarly recognition.[1]

Abstract

The Women Researcher Award recognizes academic and scientific contributions that demonstrate relevance, scholarly consistency, and engagement with emerging challenges in biomedical and pharmaceutical sciences. Gulnara Yuldasheva has contributed to the field of anti-infective drug research with particular attention to drug synergy, antimicrobial investigations, and interdisciplinary pharmaceutical approaches. Her research activities are represented through indexed scientific publications and citation-based academic visibility, indicating active participation in internationally recognized scientific communication.[1][2]

Keywords

  • Drug synergy
  • Anti-infective research
  • Pharmaceutical sciences
  • Biomedical research
  • Women in science
  • Global Diseases Research Awards

Introduction

Research in anti-infective therapeutics continues to play a significant role in addressing global public health challenges related to infectious diseases and antimicrobial resistance. Scientific investigations involving drug synergy provide insights into the combined effects of therapeutic compounds and contribute to the optimization of treatment strategies. Researchers engaged in this domain support evidence-based approaches that may improve clinical outcomes and pharmaceutical innovation.[2]

Gulnara Yuldasheva’s academic profile reflects participation in research initiatives connected with anti-infective drug development and interdisciplinary pharmaceutical studies. Her scholarly contributions demonstrate engagement with research dissemination through indexed databases and internationally accessible scientific literature. Such contributions align with the broader objectives of scientific collaboration and innovation in health-related research environments.[1]

Research Profile

The research profile of Gulnara Yuldasheva is associated with studies in anti-infective pharmacology and drug synergy analysis. Her work has contributed to the understanding of therapeutic interactions and scientific approaches relevant to infectious disease management. Indexed publications and citation metrics indicate continuing scholarly engagement within biomedical and pharmaceutical research communities.[1]

  • Affiliated with the Scientific Center for Anti-Infective Drug.
  • Research specialization includes drug synergy and anti-infective therapeutics.
  • Indexed scientific publications available through Scopus.
  • Recognized through measurable citation impact and academic visibility.
  • Engaged in interdisciplinary biomedical and pharmaceutical studies.

Research Contributions

Research contributions associated with Gulnara Yuldasheva include scientific investigations into anti-infective compounds, synergistic drug interactions, and pharmaceutical research methodologies. Such studies support broader scientific understanding related to therapeutic combinations and their relevance in infectious disease management.[2]

Drug synergy research is important for evaluating combined therapeutic effectiveness, minimizing resistance development, and identifying optimized treatment approaches. Through scholarly publication activity, Yuldasheva has contributed to ongoing scientific discussions in this specialized area of pharmaceutical sciences and biomedical investigation.[3]

Publications

The publication record associated with Gulnara Yuldasheva reflects contributions to scientific literature indexed within internationally recognized academic databases. Her scholarly output demonstrates participation in peer-reviewed communication relevant to anti-infective pharmacology and biomedical research.[1]

  1. Research studies addressing anti-infective therapeutic strategies and drug interaction analysis.
  2. Molecular Modeling of the Anti-HIV Activity Mechanism of Iodine-Containing Drugs Armenicum and FS-1Article link copied! [3]
  3. Iodine-Based Coordination Compounds: A Strategy Toward Antibiotic Potentiation [4]

Research Impact

Research impact may be evaluated through publication indexing, citation activity, and scholarly engagement across scientific platforms. The citation profile associated with Gulnara Yuldasheva demonstrates recognition within academic literature and indicates that her work has contributed to discussions related to pharmaceutical and anti-infective sciences.[1]

The documented h-index and citation metrics reflect measurable academic visibility within the scientific community. Such indicators support the significance of continued research participation and contribution to interdisciplinary biomedical knowledge dissemination.[1]

Award Suitability

The Women Researcher Award within the Global Diseases Research Awards framework recognizes scientific contributions that support research excellence, innovation, and scholarly engagement in health sciences. Gulnara Yuldasheva’s profile demonstrates alignment with these objectives through her involvement in anti-infective drug research, indexed scientific output, and measurable citation impact.[5]

Her academic activities indicate sustained participation in biomedical and pharmaceutical investigations relevant to global health and therapeutic innovation. The combination of publication visibility, research specialization, and international indexing supports the suitability of recognition within a research-oriented academic award context.[1]

Conclusion

Gulnara Yuldasheva has contributed to scientific research associated with anti-infective therapeutics and drug synergy studies through indexed publications and interdisciplinary academic engagement. Her scholarly profile reflects measurable research visibility and participation in pharmaceutical science communication. The academic contributions and citation-based impact presented within this profile demonstrate relevance to contemporary biomedical research and support recognition within the Women Researcher Award category of the Global Diseases Research Awards.[1][5]

References

  1. Elsevier. (n.d.). Scopus author details: Gulnara Yuldasheva, Author ID 21735405800. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=21735405800
  2. World Health Organization. (2023). Antimicrobial resistance and anti-infective therapeutic research.
    https://www.who.int/news-room/fact-sheets/detail/antimicrobial-resistance
  3. Yuldasheva, G. A., Argirova, R., & Ilin, A. I. (2023). Molecular modeling of the anti-HIV activity mechanism of iodine-containing drugs Armenicum and FS-1. ACS Omega, 8(9), 8617–8624
    https://doi.org/10.1021/acsomega.2c07720

  4. Shepilov, D., Askarova, D., Seisembekova, A., Turganbay, S., Jumagaziyeva, A., Bukeyeva, T., Yuldasheva, G., Temir, N., Ivanova, L. N., Zubenko, N., & Kenesheva, S. (2026). Iodine-based coordination compounds: A strategy toward antibiotic potentiation. International Journal of Molecular Sciences, 27(10), 4292.
    https://doi.org/10.3390/ijms27104292

  5. Global Diseases Research Awards. (n.d.). Women Researcher Award recognition and event information.
    https://globaldiseases.org/

Njeumi Felix | Epidemiology | Excellence in Research Award

Published on by Global Diseases Research

Excellence in Research Award

Njeumi Felix
Food and Agriculture Organization of the United Nations
Academic Profile
Affiliation Food and Agriculture Organization of the United Nations
Country Italy
Scopus ID 6506444570
Documents 32
Citations 633
h-index 13
Subject Area Epidemiology
Event Global Diseases Research Awards

Njeumi Felix is an epidemiology researcher and international scientific coordinator associated with the Food and Agriculture Organization of the United Nations. His academic and professional activities are primarily connected to infectious disease surveillance, transboundary animal disease control, and global veterinary public health initiatives. His scholarly work reflects contributions to disease eradication programs, epidemiological assessment methodologies, and collaborative international research activities addressing livestock health management and sustainable agricultural development.[1][2]

Abstract

This academic recognition article provides a scholarly overview of Njeumi Felix and his contributions to epidemiology and infectious disease research. His professional activities include research coordination, epidemiological investigations, and participation in global veterinary health initiatives. His scientific work contributes to disease surveillance systems, veterinary public health frameworks, and collaborative international efforts addressing transboundary animal diseases and livestock health management.[1][3]

Keywords

Epidemiology; Veterinary Science; Infectious Diseases; Disease Surveillance; Peste des Petits Ruminants; Global Disease Eradication; Animal Health; Veterinary Public Health; Transboundary Diseases; International Research Collaboration.

Introduction

Epidemiological research plays a significant role in understanding infectious disease transmission and strengthening international disease prevention systems. Veterinary public health initiatives have become increasingly important due to the global impact of transboundary animal diseases on agricultural economies, livestock productivity, and food security. Njeumi Felix has contributed to these scientific and institutional efforts through research coordination, disease surveillance activities, and international collaborative programs.[2]

Research Profile

The research profile of Njeumi Felix reflects scholarly engagement in epidemiology, disease surveillance, and veterinary health management. His Scopus-indexed publication record includes research articles related to infectious disease risk analysis, surveillance strategies, vaccine assessment methodologies, and global disease control initiatives.[1]

Research Contributions

Njeumi Felix has contributed to research associated with Peste des Petits Ruminants and related transboundary animal diseases. His scientific involvement includes epidemiological modeling, disease risk mapping, surveillance frameworks, and international disease eradication planning activities.[3]

Publications

Selected scientific publications associated with Njeumi Felix include studies addressing epidemiological surveillance, disease risk analysis, vaccine evaluation, and transboundary disease management strategies.[3][4]

Research Impact

The scholarly impact of Njeumi Felix is reflected through citation metrics, collaborative publications, and continued participation in global disease research initiatives. His Scopus profile indicates a significant citation record and measurable academic influence within epidemiology and veterinary science research communities.[1]

Award Suitability

Njeumi Felix demonstrates suitability for recognition within the Global Diseases Research Awards due to his sustained contributions to epidemiology, veterinary public health, and infectious disease research. His scholarly activities reflect international collaboration, scientific productivity, and engagement with disease eradication initiatives relevant to global health priorities.[5]

Conclusion

Njeumi Felix has contributed to the advancement of epidemiological research and international veterinary health initiatives through collaborative scientific work and institutional engagement. His academic profile demonstrates ongoing involvement in disease surveillance, infectious disease management, and evidence-based veterinary public health strategies. The impact of his research supports recognition within scholarly platforms dedicated to global disease research and epidemiological studies.[1][2]

References

  1. Elsevier. (n.d.). Scopus author details: Njeumi Felix, Author ID 6506444570. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6506444570
  2. Food and Agriculture Organization of the United Nations. (n.d.). Global animal health and disease control initiatives. FAO.
    https://www.fao.org/
  3. Arede, M., Beltrán-Alcrudo, D., Benfield, C., Casal, J., & Njeumi, F. (2024). Risk mapping of Peste des Petits Ruminants virus spread in nine countries surrounding the Black Sea: a spatial multicriteria decision analysis approach. Frontiers in Veterinary Science.
    https://doi.org/10.3389/fvets.2026.1783624
  4. Bodjo, C. S., et al. (2023). Peste des Petits Ruminants Vaccine: Criteria for Assessing Its Thermotolerance. Viruses.
    https://doi.org/10.3390/v17091151
  5. Global Diseases Research Awards. (n.d.). International academic recognition and disease research initiatives.
    https://globaldiseases.org/

Ting Cheng | Epidemiology | Research Excellence Award

Published on by Global Diseases Research

Dr. Ting Cheng | Epidemiology | Research Excellence Award

Shanxi Medical University | China

Dr. Cheng Ting is a medical doctor and researcher affiliated with Shanxi Medical University, recognized for her contributions to autoimmune disease research, metabolic disorders, and chronic disease management. Her academic and clinical expertise spans rheumatology, endocrinology, osteoporosis, thyroid disorders, diabetes, and systemic autoimmune diseases. Dr. Cheng has actively contributed to translational medicine through clinical research projects and scientific publications focused on improving diagnosis, treatment, and patient outcomes. She has led provincial and hospital-level research projects and collaborated with national and international scientific communities. Her research achievements include SCI-indexed publications, academic book contributions, and patented medical innovations. Dr. Cheng has also gained international recognition through invited keynote lectures at major conferences, including EULAR and APLAR. Through her dedication to medical advancement, innovation, and patient-centered research, she continues to strengthen biomedical research and healthcare development both nationally and internationally.

Professional Profile

 

Education

Dr. Cheng Ting completed her medical education in China and earned her M.D. qualification with specialized training in internal medicine, autoimmune diseases, endocrinology, and chronic disease management. Her academic background provided extensive knowledge in clinical medicine, biomedical sciences, diagnostic methodologies, and evidence-based healthcare practices. During her advanced medical training, she developed strong expertise in rheumatology, osteoporosis research, metabolic diseases, and immune-related disorders. Her educational journey emphasized both theoretical medical sciences and practical clinical applications, enabling her to integrate patient care with scientific investigation. She further enhanced her academic profile through continuous participation in scientific conferences, professional workshops, and interdisciplinary medical collaborations. Her educational development also includes contributions to academic literature and participation in medical publishing activities. Through continuous learning and professional development, Dr. Cheng has established a strong academic foundation that supports her ongoing research in autoimmune diseases, metabolic health, chronic disease prevention, and translational clinical medicine.

Professional Experience

Dr. Cheng Ting has extensive professional experience in clinical medicine, biomedical research, and chronic disease management. She currently serves at Shanxi Medical University, where she combines patient care with advanced scientific research. Her clinical expertise includes the diagnosis and management of autoimmune diseases, osteoporosis, thyroid disorders, diabetes, and metabolic syndromes. Throughout her career, she has led two provincial and hospital-level research projects aimed at improving treatment strategies and healthcare outcomes. She has authored and co-authored several SCI-indexed research papers and contributed to multiple academic books related to medical sciences. Dr. Cheng also holds numerous national patents, reflecting her commitment to innovation and translational medicine. In addition to research and clinical responsibilities, she has been invited to present keynote speeches at internationally recognized conferences, including EULAR and APLAR. Her professional career demonstrates leadership, scientific excellence, and dedication to advancing global healthcare and medical research.

Research Interest 

Dr. Cheng Ting focuses her research on autoimmune diseases, metabolic disorders, rheumatology, endocrinology, and chronic disease prevention. Her studies investigate the mechanisms, diagnosis, and treatment strategies for conditions such as systemic sclerosis, osteoporosis, thyroid diseases, diabetes, and immune-mediated inflammatory disorders. She is particularly interested in translational medicine approaches that connect laboratory discoveries with clinical applications to improve patient outcomes. Her recent scientific contributions include research on viral infections and autoimmune diseases, as well as the clinical implications of nutritional interventions such as low-carbohydrate diets in autoimmune conditions. Dr. Cheng also emphasizes chronic disease management and preventive healthcare strategies aimed at reducing disease burden and improving long-term quality of life. Through multidisciplinary collaborations and evidence-based research methodologies, she continues to contribute to advancing biomedical science and precision medicine. Her research supports the development of innovative therapeutic approaches and improved healthcare systems for patients with autoimmune and metabolic disorders.

Awards and Honors

Dr. Cheng Ting has received several recognitions for her outstanding contributions to medical research, innovation, and healthcare advancement. One of her most notable achievements is receiving the Second Prize of the Shanxi Provincial Scientific and Technological Progress Award, which honors significant scientific contributions with practical healthcare impact. Her innovative work is further reflected in her ownership of 20 national patents related to medical technologies and healthcare solutions. Dr. Cheng has also earned professional recognition through invitations to deliver keynote speeches at major international and regional scientific conferences, including the European League Against Rheumatism (EULAR) and the Asia Pacific League of Associations for Rheumatology (APLAR). Her academic accomplishments include publishing multiple SCI-indexed papers and contributing to five academic books in the field of medicine and chronic disease management. These honors demonstrate her commitment to scientific innovation, translational medicine, clinical excellence, and international collaboration in biomedical and autoimmune disease research.

Conclusion

Dr. Cheng Ting  is a dedicated clinician, researcher, and innovator whose work significantly contributes to autoimmune disease research, metabolic medicine, and chronic disease management. With strong academic training, clinical expertise, research leadership, and international scientific engagement, she has established herself as an emerging contributor to biomedical and translational medicine. Her achievements include SCI-indexed publications, national patents, prestigious research awards, and keynote presentations at internationally recognized conferences. Dr. Cheng’s commitment to improving healthcare through scientific innovation and evidence-based medicine highlights her growing influence in global medical research. Her continued focus on interdisciplinary collaboration, translational medicine, and patient-centered healthcare positions her for further academic and professional excellence in the international biomedical research community.

Publications Top Noted

  • The application of low-carbohydrate diet in autoimmune diseases: Mechanisms, evidence, and prospects for clinical translation
    Authors: Ming-Fu Lu
    Citation: Autoimmunity Reviews | DOI: 10.1016/j.autrev.2026.104071
  •  Mendelian randomization unveils genetic causal relationships between viral infections and systemic sclerosis
    Authors: Ting Cheng
    Year: 2025
    Citation: Scientific Reports | DOI: Not provided